![All lanes : Anti-ACSM2A antibody [EPR13330] (ab181204) at 1/2000 dilutionLane 1 : Human fetal liver lysateLane 2 : Human fetal kidney lysateLysates/proteins at 20 µg per lane.SecondaryGoat Anti-Rabbit IgG H&L (HRP) (ab136636) at 1/500 dilution](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_1/2079_ab181204-215110-ab1812041.jpg)
All lanes : Anti-ACSM2A antibody [EPR13330] (ab181204) at 1/2000 dilutionLane 1 : Human fetal liver lysateLane 2 : Human fetal kidney lysateLysates/proteins at 20 µg per lane.SecondaryGoat Anti-Rabbit IgG H&L (HRP) (ab136636) at 1/500 dilution
Immunohistochemical analysis of paraffin-embedded Human hepatocellular carcinoma tissue labeling ACSM2A with ab181204 at a 1/250 dilution. Prediluted (ready to use) HRP Polymer for Rabbit IgG was used as a secondary antibody. Counter stain: Hematoxylin
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling ACSM2A with ab181204 at a 1/250 dilution. Prediluted (ready to use) HRP Polymer for Rabbit IgG was used as a secondary antibody. Counter stain: Hematoxylin
Immunoprecipitation of Human fetal kidney labeling ACSM2A using ab181204 at a 1/50 dilution (lane 1). Lane 2 shows the negative control. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as a secondary antibody at a dilution of 1/1500. Blocking/dilution buffer and concentration: 5% NFDM/TBST.59 KDa: Mature form64 KDa: Full length